NovoCure (NVCR) Non-Current Debt (2015 - 2026)
NovoCure (NVCR) posted Non-Current Debt of $195.9 million for Q2 2026, little changed sequentially from $195.5 million in Q1 2026, and up 100.69% YoY from $97.6 million in Q2 2025.
NovoCure (NVCR) Non-Current Debt (2015 - 2026) Analysis & Trends
NovoCure has reported Non-Current Debt for 12 years, with the latest figure at $195.9 million in Q2 2026.
- Quarterly Non-Current Debt rose 100.69% year-over-year to $195.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $195.9 million (up 100.69% YoY) and the FY2025 annual result came in at $195.0 million, up 100.46% from the prior year.
- Non-Current Debt steadied at $195.9 million in Q2 2026 per NVCR's latest filing, from $195.5 million in the prior quarter.
- Over five years, Non-Current Debt peaked at $569.7 million in Q1 2024 and troughed at $97.0 million in Q2 2024.
- A 5-year average of $340.9 million and a median of $195.9 million in 2026 frame the typical range for Non-Current Debt.
- The sharpest annual moves came in 2024 and 2026: Non-Current Debt slumped 82.9% in 2024, then jumped 100.69% in 2026.
- Over 5 years, Non-Current Debt stood at $565.5 million in 2022, then climbed by 0.44% to $568.0 million in 2023, then tumbled by 82.87% to $97.3 million in 2024, then soared by 100.46% to $195.0 million in 2025, then increased by 0.43% to $195.9 million in 2026.
- According to Business Quant data, Non-Current Debt over the past three periods registered $195.9 million, $195.5 million, and $195.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 29.60 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 14.19 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 10.92 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 598.70 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 10.09 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 7.34 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 1.65 Bn |
| 10 | NovoCure | 2.06 Bn | 1.62 Bn | 142.48 Mn | 195.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 195.89 Mn |
| Mar 31, 2026 | 195.46 Mn |
| Dec 31, 2025 | 195.05 Mn |
| Sep 30, 2025 | 194.64 Mn |
| Jun 30, 2025 | 97.61 Mn |
| Mar 31, 2025 | 97.45 Mn |
| Dec 31, 2024 | 97.30 Mn |
| Sep 30, 2024 | 97.15 Mn |
| Jun 30, 2024 | 96.96 Mn |
| Mar 31, 2024 | 569.65 Mn |
| Sep 30, 2023 | 567.99 Mn |
| Jun 30, 2023 | 567.15 Mn |
| Mar 31, 2023 | 566.32 Mn |
| Dec 31, 2022 | 565.51 Mn |
| Sep 30, 2022 | 564.68 Mn |
| Jun 30, 2022 | 563.85 Mn |
| Mar 31, 2022 | 563.03 Mn |
| Dec 31, 2021 | 562.22 Mn |
| Sep 30, 2021 | 561.39 Mn |
| Jun 30, 2021 | 560.56 Mn |